Similarly, our previous studies revealed that EGF treatment regulates TLR-2-induced inflammatory reaction in human epidermal keratinocytes [20], and topical treatment of EGF relieved S. aureus-induced inflammation and AD-like skin lesions in Nc/Nga mice [18]. This evidence concerns the gene TLR2 and Alzheimer disease.